Month: May 2012

ZURICH (Reuters) – A Novartis experimental lung drug to treat smokers’ cough was superior to a placebo in improving lung function over a one-year period and had similar efficacy to a rival drug from Pfizer and Boehringer Ingelheim, the Swiss drugmaker said on Thursday. The Phase III GLOW2 trial showed a 50 mcg once-daily dose of NVA237 improved lung function, symptom relief and quality of life over a one-year period in patients with chronic obstructive pulmonary disease (COPD), commonly referred to as smokers cough, compared with a placebo. …

Walk into any grocery store, and you'll see aisles brimming with low fat and fat- free foods. Yet obesity remains a growing epidemic. Nearly one-third.
www.healthboards.com/…/900475-diet-foods-make-you-fatter…

Researchers developed a vaccine that helps prevent recurrence of breast cancer.

Doctors increasingly are ditching the prescription pad. The latest count shows more than a third of the nation’s prescriptions now are electronic.